C-28 modified betulinic acid analogs are potent HIV entry inhibitors, while C-3 modified betulinic acid derivatives function by blocking virus maturation. [127] Among these bevirimat (Figure 23 ...

As heart failure patients, the TAVI population studied already is recommended to be treated with an SGLT2 inhibitor, noted ...

Omeros has announced that the activation of clinical trial sites for patient enrolment is now in progress for its Phase III ...

Since these inhibitors act directly on the virus without affecting human cells ... delta, and omicron BA.5) , blocking viral ...

According to Straits Research, The Mold Inhibitors Market size was valued at USD XX Billion in 2023 to USD 3.03 Billion by ...

US regulators have once again declined to approve Hengrui Pharmaceuticals' (SHA: 600276) PD-1 inhibitor camrelizumab, further delaying the drug's entry into the American market.

Dolutegravir is an HIV integrase strand transfer inhibitor (INSTI) that does not require pharmacokinetic boosting, has a long half-life allowing for once-daily dosing in treatment-naive patients ...

The FDA has approved Tremfya as the “first and only” interleukin-23 inhibitor that offers both IV and fully subcutaneous ...

Guggenheim initiated coverage on shares of Assembly Biosciences (NASDAQ:ASMB – Free Report) in a report released on Tuesday morning, Marketbeat reports. The brokerage issued a buy rating and a $31.00 ...